Low Density Lipoprotein Receptor Anticorps
(Low Density Lipoprotein Receptor (LDLR))
Choisissez l’un des 127 anticorps LDLR de notre liste de produits basés sur 11 publications et 47 images de validation.
Découvrez des anticorps LDLR fiables issus d’une large sélection de fabricants renommés. Notre portefeuille permet une détection précise de LDLR dans plusieurs espèces, y compris Human, Mouse, Rat, Cow, Dog, Guinea Pig, Monkey, Pig, Rabbit, Hamster, Horse, et prend en charge diverses applications de recherche telles que WB, FACS, ELISA, IHC, IF (p).
Trouvez rapidement l’anticorps adapté grâce à nos outils de recherche, de filtrage et de comparaison. Chaque page produit fournit des données de validation détaillées, des références bibliographiques et des retours d’utilisateurs. Contrairement aux ressources dédiées uniquement à la comparaison, vous pouvez acheter directement les anticorps sur notre site. Choisissez parmi des anticorps polyclonaux, monoclonaux ou recombinants LDLR, issus de différents hôtes tels que Rabbit, Mouse, Chicken. Parcourez nos produits ci-dessous et commandez directement pour soutenir vos recherches en toute confiance.
Les noms alternatifs de LDLR sont LDLR, Ldlr, ldlra, ldlr.S, ldlr.L.
| Catalog no. | Produit | Reactivité | Hôte / Clonalité | Application | Prix et délai de livraison |
|---|---|---|---|---|---|
| LDLR anticorps (AA 705-860) (Cy3) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| LDLR anticorps (AA 35-843) (Fluoro488) | Humain, Rat | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| LDLR anticorps (AA 705-860) (Fluoro488) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| LDLR anticorps (AA 705-860) (Fluoro647) | Humain | Lapin Polyclonal |
|
852,50 €
Voir le prix
|
|
| LDLR anticorps (AA 35-843) (Fluoro647) | Humain, Rat | Lapin Polyclonal |
|
852,50 €
Voir le prix
|
|
| LDLR anticorps (AA 35-843) (PE) | Humain, Rat | Lapin Polyclonal |
|
1.017,50 €
Voir le prix
|
|
| LDLR anticorps (AA 705-860) (PE) | Humain | Lapin Polyclonal |
|
1.017,50 €
Voir le prix
|
Primary Antibody
- WB (Western Blotting: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Cy3
- Isotype
- IgG
- Epitope
- AA 705-860
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Reactivité
- Humain, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro488
- Isotype
- IgG
- Epitope
- AA 35-843
Primary Antibody
- WB (Western Blotting: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro488
- Isotype
- IgG
- Epitope
- AA 705-860
Primary Antibody
- WB (Western Blotting: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro647
- Isotype
- IgG
- Epitope
- AA 705-860
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Reactivité
- Humain, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro647
- Isotype
- IgG
- Epitope
- AA 35-843
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Reactivité
- Humain, Rat
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- PE
- Isotype
- IgG
- Epitope
- AA 35-843
Primary Antibody
- WB (Western Blotting: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- PE
- Isotype
- IgG
- Epitope
- AA 705-860
Dernières publications pour nos Low Density Lipoprotein Receptor Anticorps
: "VEGF-B signaling impairs endothelial glucose transcytosis by decreasing membrane cholesterol content." dans: EMBO reports, Vol. 21, Issue 7, pp. e49343, (2020) (PubMed).
: "Loss-of-function PCSK9 mutants evade the unfolded protein response sensor GRP78 and fail to induce endoplasmic reticulum stress when retained." dans: The Journal of biological chemistry, Vol. 293, Issue 19, pp. 7329-7343, (2019) (PubMed).
: "Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics." dans: Molecular therapy : the journal of the American Society of Gene Therapy, Vol. 27, Issue 1, pp. 188-199, (2019) (PubMed).
: "Clinical relevance of cholesterol homeostasis genes in colorectal cancer." dans: Biochimica et biophysica acta. Molecular and cell biology of lipids, Vol. 1864, Issue 10, pp. 1314-1327, (2019) (PubMed).
: "Besnoitia besnoiti infection alters both endogenous cholesterol de novo synthesis and exogenous LDL uptake in host endothelial cells." dans: Scientific reports, Vol. 9, Issue 1, pp. 6650, (2019) (PubMed).
: "Global inactivation of carboxylesterase 1 (Ces1/Ces1g) protects against atherosclerosis in Ldlr-/-mice." dans: Scientific reports, Vol. 7, Issue 1, pp. 17845, (2018) (PubMed).
: "The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins." dans: Molecular metabolism, Vol. 16, pp. 88-99, (2018) (PubMed).
: "Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex." dans: Scientific reports, Vol. 8, Issue 1, pp. 16845, (2018) (PubMed).
: "Differential Response of B Cells to an Immunogen, a Mitogen and a Chemical Carcinogen in a Mouse Model System" dans: Asian Pacific journal of cancer prevention : APJCP, Vol. 19, Issue 1, pp. 81-90, (2018) (PubMed).
: "Comparing expression and activity of PCSK9 in SPRET/EiJ and C57BL/6J mouse strains shows lack of correlation with plasma cholesterol." dans: Molecular genetics and metabolism reports, Vol. 10, pp. 11-17, (2017) (PubMed).
: "Loss-of-function PCSK9 mutants evade the unfolded protein response sensor GRP78 and fail to induce endoplasmic reticulum stress when retained." dans: The Journal of biological chemistry, Vol. 293, Issue 19, pp. 7329-7343, (2019) (PubMed).
: "Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics." dans: Molecular therapy : the journal of the American Society of Gene Therapy, Vol. 27, Issue 1, pp. 188-199, (2019) (PubMed).
: "Clinical relevance of cholesterol homeostasis genes in colorectal cancer." dans: Biochimica et biophysica acta. Molecular and cell biology of lipids, Vol. 1864, Issue 10, pp. 1314-1327, (2019) (PubMed).
: "Besnoitia besnoiti infection alters both endogenous cholesterol de novo synthesis and exogenous LDL uptake in host endothelial cells." dans: Scientific reports, Vol. 9, Issue 1, pp. 6650, (2019) (PubMed).
: "Global inactivation of carboxylesterase 1 (Ces1/Ces1g) protects against atherosclerosis in Ldlr-/-mice." dans: Scientific reports, Vol. 7, Issue 1, pp. 17845, (2018) (PubMed).
: "The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins." dans: Molecular metabolism, Vol. 16, pp. 88-99, (2018) (PubMed).
: "Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex." dans: Scientific reports, Vol. 8, Issue 1, pp. 16845, (2018) (PubMed).
: "Differential Response of B Cells to an Immunogen, a Mitogen and a Chemical Carcinogen in a Mouse Model System" dans: Asian Pacific journal of cancer prevention : APJCP, Vol. 19, Issue 1, pp. 81-90, (2018) (PubMed).
: "Comparing expression and activity of PCSK9 in SPRET/EiJ and C57BL/6J mouse strains shows lack of correlation with plasma cholesterol." dans: Molecular genetics and metabolism reports, Vol. 10, pp. 11-17, (2017) (PubMed).
Pseudonymes pour Low Density Lipoprotein Receptor Anticorps
low density lipoprotein receptor (LDLR) Anticorpslow density lipoprotein receptor (Ldlr) Anticorps
low density lipoprotein receptor a (ldlra) Anticorps
low density lipoprotein receptor S homeolog (ldlr.S) Anticorps
low density lipoprotein receptor L homeolog (ldlr.L) Anticorps
FH Anticorps
FHC Anticorps
fhc Anticorps
Hlb301 Anticorps
LDLA Anticorps
LDLCQ2 Anticorps
ldlcq2 Anticorps
ldlr Anticorps
ldlr-a Anticorps
ldlr-b Anticorps
ldlr2-a Anticorps
LDLRA Anticorps
LDL receptor-2 Anticorps
LDL receptor 1 Anticorps
Avez-vous cherché autre chose?
- LOR Anticorps
- LONRF3 Anticorps
- LONP2 Anticorps
- LONP1 Anticorps
- LOH12CR1 Anticorps
- LNX1 Anticorps
- LNPEP Anticorps
- LMX1B Anticorps
- LMX1A Anticorps
- LMTK3 Anticorps
- LMTK2 Anticorps
- LMO7 Anticorps
- LMO4 Anticorps
- LMO3 Anticorps
- LMO2 Anticorps
- LMO1 Anticorps
- LMF2 Anticorps
- LMF1 Anticorps
- LMCD1 Anticorps
- LMBRD1 Anticorps
- LOX Anticorps
- LOXL1 Anticorps
- LOXL2 Anticorps
- LOXL3 Anticorps
- LOXL4 Anticorps
- LPAR3 Anticorps
- LPAR4 Anticorps
- LPAR6 Anticorps
- LPCAT1 Anticorps
- LPCAT2 Anticorps
- LPCAT3 Anticorps
- LPGAT1 Anticorps
- LPHN2 Anticorps
- LPHN3 Anticorps
- LPIN3 Anticorps
- LPO Anticorps
- LPP Anticorps
- LPPR1 Anticorps
- LPPR3 Anticorps
- LPPR4 Anticorps
Vous êtes ici:
